Oct 7
|
5 Large Drug Stocks to Watch From a Thriving Industry
|
Aug 30
|
Bayer Initiates Late-Stage Study on Investigational NSCLC Drug
|
Aug 29
|
Bayer, NextRNA to Develop Therapeutics Targeting Oncology
|
Aug 28
|
Bayer teams up with lncRNA-focused NextRNA in $547m deal
|
Aug 28
|
Bayer partners with RNA drugmaker to develop new cancer therapies
|
Aug 27
|
US says Bioceres genetically modified wheat safe to grow
|
Jul 26
|
Monsanto agrees to $160 million settlement with Seattle over pollution in the Duwamish River
|
Jul 25
|
Bayer's Monsanto to pay $160 million to resolve Seattle's PCB contamination lawsuit
|
Jun 7
|
Bayer and PAPACKS to redefine consumer health packaging
|
Apr 5
|
Judge slashes Bayer $1.56 billion Roundup verdict to $611 million
|
Apr 5
|
Bayer’s $1.5 Billion Roundup Verdict Slashed to $600 Million
|
Jan 26
|
UPDATE 1-Bayer ordered to pay $2.25 billion in latest Roundup trial
|
Jan 26
|
Bayer ordered to pay $2.25 billion in latest Roundup trial
|
Jan 25
|
12 Best German Dividend Stocks
|
Jan 19
|
Asian Equities Rise as Tech Rally Bolsters Mood: Markets Wrap
|
Jan 18
|
Bayer Moves Away From Breakup Despite Investor Pressure
|
Jan 18
|
Bayer holds off on break-up to focus on management revamp for now -sources
|
Jan 18
|
UPDATE 2-Bayer holds off on break-up to focus on management revamp for now -sources
|
Jan 18
|
Bayer signals ‘significant’ layoffs in plan to shrink bureaucracy
|
Jan 9
|
Regeneron (REGN) Down as Q4 Eylea Preliminary Sales Disappoint
|